Related references
Note: Only part of the references are listed.Establishing Serum Reference Ranges for Antihypertensive Drugs
Stine Rognstad et al.
THERAPEUTIC DRUG MONITORING (2021)
The Current Status of Devices for the Treatment of Resistant Hypertension
Michael Kunz et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy
Sabrina Ritscher et al.
PLOS ONE (2020)
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
Martin Schulz et al.
CRITICAL CARE (2020)
Blood plasma level determination using an automated LC-MSn screening system and electronically stored calibrations exemplified for 22 drugs and two active metabolites often requested in emergency toxicology
Achim T. Caspar et al.
DRUG TESTING AND ANALYSIS (2019)
Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment
A. M. Punt et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence
Lilian H. J. Richter et al.
ANALYTICA CHIMICA ACTA (2019)
Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers - drug classes with low adherence in antihypertensive therapy
Sabrina Ritscher et al.
SCIENTIFIC REPORTS (2019)
Drug nonadherence is a common but often overlooked cause of hypertensive urgency and emergency at the emergency department
Naomi Overgaauw et al.
JOURNAL OF HYPERTENSION (2019)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
C. Hiemke et al.
PHARMACOPSYCHIATRY (2018)
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples
Valeria Avataneo et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2018)
Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence
Pankaj Gupta et al.
HYPERTENSION (2017)
High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC MS/MS
Bart C. H. van der Nagel et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients
Idir Hamdidouche et al.
JOURNAL OF HYPERTENSION (2017)
Drug adherence in hypertension
M. Burnier
PHARMACOLOGICAL RESEARCH (2017)
Liquid chromatography-high resolution-tandem mass spectrometry using Orbitrap technology for comprehensive screening to detect drugs and their metabolites in blood plasma
Andreas G. Helfer et al.
ANALYTICA CHIMICA ACTA (2017)
How to Screen for Non-Adherence to Antihypertensive Therapy
Pankaj Gupta et al.
CURRENT HYPERTENSION REPORTS (2016)
Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2016)
UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients
Amedeo De Nicolo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - Exemplified for cardiovascular drugs
Andreas G. Helfer et al.
ANALYTICA CHIMICA ACTA (2015)
Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis
Sebastian Ewen et al.
CLINICAL RESEARCH IN CARDIOLOGY (2015)
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry ( HP LC-MS/MS) urine analysis
Maciej Tomaszewski et al.
HEART (2014)
Recent developments in urinalysis of metabolites of new psychoactive substances using LC-MS
Frank T. Peters
BIOANALYSIS (2014)
Simultaneous determination of a broad range of cardiovascular drugs in plasma with a simple and efficient extraction/clean up procedure and chromatography-mass spectrometry analysis
Lei Liu et al.
RSC ADVANCES (2014)
Resistant hypertension? Assessment of adherence by toxicological urine analysis
Oliver Jung et al.
JOURNAL OF HYPERTENSION (2013)
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
Martin Schulz et al.
CRITICAL CARE (2012)
Risk Factors Promoting Hypertensive Crises: Evidence From a Longitudinal Study
Ardan M. Saguner et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmosphericpressure chemical ionization or electrospray ionization
Daniela Remane et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
Measuring adherence to behavioral and medical interventions
MZ Vitolins et al.
CONTROLLED CLINICAL TRIALS (2000)
Share Paper
